There are some reports that analysis of E-cadherin protein expression may be used as a marker of high risk of malignancy (21), for example, for the prognosis of oropharyngeal squamous cell carcinoma (OPSCC) or head neck squamous cell carcinoma (HNSCC). The gene discussed is CDH1; the disease is oropharynx squamous cell carcinoma.